ArticleOphthalmology and therapy2026

A Phase III Randomized Trial Comparing Efficacy, Safety, and Immunogenicity of ZRC-3285 vs. Eylea

Mudit Bansal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.